Guided Therapeutics Inc. logo

Guided Therapeutics Inc. (GTHP)

Market Closed
12 Dec, 20:00
OTC PINK OTC PINK
$
0. 27
+0.05
+23.29%
$
11.05M Market Cap
- P/E Ratio
0% Div Yield
17,910 Volume
- Eps
$ 0.22
Previous Close
Day Range
0.22 0.27
Year Range
0.06 0.32
Want to track GTHP and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

GTHP closed Friday higher at $0.27, an increase of 23.29% from Thursday's close, completing a monthly increase of 8% or $0.02. Over the past 12 months, GTHP stock gained 80%.
GTHP is not paying dividends to its shareholders.
The last earnings report, released on Aug 14, 2025, missed the consensus estimates by -0.01%. On average, the company has fell short of earnings expectations by -0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on OTC PINK (USD).

GTHP Chart

Guided Therapeutics Inc. (GTHP) FAQ

What is the stock price today?

The current price is $0.27.

On which exchange is it traded?

Guided Therapeutics Inc. is listed on OTC PINK.

What is its stock symbol?

The ticker symbol is GTHP.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 11.05M.

Has Guided Therapeutics Inc. ever had a stock split?

No, there has never been a stock split.

Guided Therapeutics Inc. Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Dr. Mark L. Faupel Ph.D. CEO
OTC PINK Exchange
40171F501 CUSIP
US Country
4 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Guided Therapeutics, Inc. is an innovative medical technology company primarily focused on the development and commercialization of non-invasive diagnostic devices. The inception of this company traces back to 1992 under the name SpectRx, Inc., before it underwent a name change to Guided Therapeutics, Inc. in February 2008. Situated in Norcross, Georgia, the company is dedicated to advancing the early detection of diseases through their groundbreaking technologies, with a particular emphasis on the detection of cervical cancer. Their mission is to enhance the quality of care for patients by providing painless, non-invasive, and point-of-care diagnostic solutions.

Products and Services

  • LuViva

LuViva is the flagship product of Guided Therapeutics, Inc., representing a cutting-edge approach to the early detection of cervical cancer and its precancerous states. This non-invasive medical device is designed to scan the cervix using specific wavelengths of light, capturing the reflective and fluorescent properties inherent to healthy or diseased cervical tissue. The core benefit of LuViva lies in its ability to provide immediate results without the discomfort or invasiveness of traditional biopsy methods, thereby streamlining the diagnostic process and facilitating early intervention. This tool exemplifies the company's dedication to improving patient outcomes through innovative medical technology.

Contact Information

Address: 5835 Peachtree Corners East
Phone: 770 242 8723